Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Treatment    save search

Jaypirca® (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a BCL-2 Inhibitor
Published: 2023-12-01 (Crawled : 23:00) - prnewswire.com
LLY 2 d | $584.04 -1.18% 0.34% 3.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

jaypirca fda approved treatment leukemia
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
Published: 2023-11-30 (Crawled : 00:00) - biospace.com/
BIOR | $1.35 8.87% -2.96% 12M twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: 1.65% H: 0.0% C: 0.0%

bt-600 fda treatment clearance application therapeutics
FDA Grants Priority Review for Supplemental Biologics License Application (sBLA) of PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Published: 2023-11-30 (Crawled : 22:00) - prnewswire.com
PFE | $28.91 -5.12% 0.0% 100M twitter stocktwits trandingview |
Health Technology
| | O: -4.15% H: 0.0% C: 0.0%

padcev fda license review bladder cancer treatment application grants
Acute Myocardial Infarction Treatment Market to Show Immense Growth at a CAGR of 7.7% During the Study Period (2019-2032), Predicts DelveInsight
Published: 2023-11-30 (Crawled : 22:00) - prnewswire.com
LLY 2 d | $584.04 -1.18% 0.34% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.0% C: 0.0%

treatment show growth study market
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
NLTX | $3.5 1.16% 0.0% 35K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

ngn-401 treatment trial
Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
BNTC | $3.22 1.26% 1.86% 11K twitter stocktwits trandingview |
Health Technology
| | O: 0.63% H: 8.29% C: -0.63%

bb-301 candidate treatment biopharma trial therapy
Acadia Pharmaceuticals Initiates Pivotal Phase 3 Study of Carbetocin (ACP-101) for the Treatment of Hyperphagia in Prader-Willi Syndrome
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
ACAD G | $22.6 1.44% 0.0% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 1.04% H: 0.0% C: 0.0%

acp-101 treatment pharmaceuticals study
Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet's Disease
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
SNGX | $0.73 75.73% -5.49% 7M twitter stocktwits trandingview |
Health Technology
| | O: 32.76% H: 0.0% C: 0.0%

fda disease treatment clearance trial
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
SNYNF | $94.0 1.34% 1.34% 860 twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 0.0% C: 0.0%
TEVA | $9.71 -1.12% 0.0% 6.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 3.73% C: 1.87%
SNY | $46.72 -0.06% 0.06% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -1.09% H: 0.0% C: 0.0%

disease treatment collaboration teva deal
LHC Group Gets Center-Stage Treatment At UnitedHealth Group’s Investor Day
Published: 2023-11-30 (Crawled : 15:00) - lhcgroup.com
LHCG | $169.81 0.47% -0.03% 0 twitter stocktwits trandingview |
Health Services
| Email alert Add to watchlist

day group treatment
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
Published: 2023-11-29 (Crawled : 20:00) - biospace.com/
KRTX | $196.53 2.78% 1.77% 230K twitter stocktwits trandingview |
Health Technology
| | O: 0.74% H: 3.66% C: 0.99%

drug food treatment schizophrenia application therapeutics
Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
Published: 2023-11-29 (Crawled : 15:30) - biospace.com/
KRTX | $196.53 2.78% 1.77% 230K twitter stocktwits trandingview |
Health Technology
| | O: 0.74% H: 3.66% C: 0.99%

drug food treatment schizophrenia application therapeutics
Inspira Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients
Published: 2023-11-29 (Crawled : 14:00) - prnewswire.com
IINN | $1.0999 0.91% 0.01% 2.5K twitter stocktwits trandingview |
Manufacturing
| | O: 10.78% H: 1.77% C: -5.31%

treatment bloodstream infections
Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera’s Next Generation Oral Peptide Platform
Published: 2023-11-29 (Crawled : 13:30) - globenewswire.com
ENTX | $0.6554 -7.68% 7.25% 19K twitter stocktwits trandingview |
Health Technology
| | O: 2.55% H: 1.42% C: -2.88%

eb613 osteoporosis treatment ongoing potential results study platform
FDA Accepts Arcutis’ Supplemental New Drug Application for Roflumilast Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to Age 6
Published: 2023-11-29 (Crawled : 13:00) - globenewswire.com
ARQT M | $1.99 8.15% 0.0% 2.9M twitter stocktwits trandingview |
Health Technology
| | O: 3.43% H: 0.0% C: 0.0%

fda drug children dermatitis treatment application
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
Published: 2023-11-29 (Crawled : 12:30) - globenewswire.com
VVOS | $19.9 -18.78% -8.84% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: 172.67% H: 0.0% C: 0.0%

fda device treatment clearance therapeutics
BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis
Published: 2023-11-29 (Crawled : 12:00) - globenewswire.com
PHGE | $0.258 -0.39% 0.0% 370K twitter stocktwits trandingview |
Health Technology
| | O: -23.36% H: 0.0% C: 0.0%

bx004 positive treatment fibrosis topline infections trial results
Perma-Fix Joint Venture Receives Notice of Intent to Award European Waste Treatment Contract Valued at up to EUR 50 Million
Published: 2023-11-28 (Crawled : 22:00) - globenewswire.com
PESI | $7.09 -2.74% -2.26% 63K twitter stocktwits trandingview |
Industrial Services
| | O: 5.3% H: 12.81% C: 8.78%

award contract treatment
Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the Journal of the American Medical Association
Published: 2023-11-28 (Crawled : 16:00) - globenewswire.com
CHRS | $2.3 7.98% -0.04% 3M twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 12.83% C: 10.47%

piter-02 association positive publication treatment medical trial results
First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash™ - for Treatment of Acute Pulmonary Embolism
Published: 2023-11-28 (Crawled : 15:30) - biospace.com/
PEN | $227.75 2.55% 0.0% 380K twitter stocktwits trandingview |
Health Technology
| | O: -0.72% H: 0.59% C: -2.08%

treatment lightning
Gainers vs Losers
77% 23%

Top 10 Gainers
ID 4 | $0.077 -9.41% 25.97% 420K twitter stocktwits trandingview |
Finance

BKKT 4 | $1.88 25.33% 14.89% 4.8M twitter stocktwits trandingview |

MGLD | $1.03 7.77% 14K twitter stocktwits trandingview |
Manufacturing

CZOO | $0.4316 -6.52% 6.7% 65K twitter stocktwits trandingview |

AUMN | $0.562 0.34% 4.5% 360K twitter stocktwits trandingview |
Non-Energy Minerals

SAIC 4 | $119.92 2.14% 4.24% 460K twitter stocktwits trandingview |
Technology Services

CULP 4 | $5.06 -0.59% 3.95% 29K twitter stocktwits trandingview |
Process Industries

LGL 4 | $4.94 1.23% 3.04% 15K twitter stocktwits trandingview |
Electronic Technology

TELL | $0.65 6.73% 2.99% 41M twitter stocktwits trandingview |
Energy Minerals

CVNA 4 | $35.2 12.39% 2.84% 12M twitter stocktwits trandingview |
Retail Trade


Your saved searches
Save your searches and get alerts when important news are released.